Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector
Sort by: Date|Relevance

Biopharma's Early Data Show Immunotherapy's Efficacy in Ovarian Cancer

The "encouraging" data for this drug candidate as a monotherapy is the focus of an H.C. Wainwright & Co. report. In a March 26 research note, analyst Joseph Pantginis reported that IMV Inc.'s (IMV:TSX; IMMVD:OTCQX) preliminary monotherapy data confirmed the efficacy o...
Streetwise Reports | April 1, 2019 |

Biopharma Continues 'Positive Push Forward in Breast Cancer'

The latest clinical trial results and next step are reviewed in an H.C. Wainwright & Co. report. In a Dec. 26 research note, analyst Joseph Pantginis reported that H.C. Wainwright & Co. increased its target price to AU$0.20 from AU$0.16 and maintained its Buy recommen...
Streetwise Reports | December 30, 2019 |

Explorer is Finding Up to 26 Grams of Gold from Rock Samples

Riverside Resources (TSX.V: RRI | OTCQB: RVSDF In this exclusive interview we joined with Dr. John-Mark Staude and Erika Sweeney of Riverside Resources https://www.rivres.com/ (TSX.V: RRI | OTCQB: RVSDF ), as we discussio...
Maurice Jackson | April 22, 2020 |

Buzz on the Bullboards: Looking for volatility-proof stocks?

This week, investors witnessed significant developments in Canadian and U.S. markets, with attention drawn to the pivotal decisions made by central banks and notable movements in key sectors. Let’s get into the highlights of the past week’s...
Jonathon Brown | April 11, 2024 |

Standard Lithium Arranges C$5 Million Convertible Loan Financing

The Critical Investor delves into a lithium company's financing and its implications. It seems more and more likely that Standard Lithium Ltd. (SLL:TSX.V; STLHF:OTCQX; FRA: S5L) is displaying a serious commitment of giant JV partner Lanxess these days, with constr...
Streetwise Reports | November 6, 2019 |

Want a Surging Investment Opportunity in 2021? Look no Further than Esports

(Image via www.virtualpitstop.gg) Despite most of our social plans being ruined in 2020, one industry that has not only remained afloat during the COVID-19 pandemic, but thrived, is esports. In fact, gaming market analytics company NewZoo stated that the industry g...
Jonathon Brown | April 26, 2021 |

Trial Milestone Reached; U.K.-Based Biopharma Gets $15 Million

The first patient has been treated in the second cohort of a Phase 2 study of a gene therapy targeting Parkinson's disease, explained an H.C. Wainwright & Co. report. In an April 30 research note, analyst Joseph Pantginis reported that Oxford Biomedica Plc ...
Streetwise Reports | May 9, 2019 |

After Biotech Dives Deeper Into Melanoma Data, It 'Continues to Impress'

Details from this clinical program are discussed, along with Q2/19 earnings and the next stock catalyst, in an H.C. Wainwright & Co. report. In an Aug. 23 research note, H.C. Wainwright & Co. analyst Joseph Pantginis reported the highlights from Targovax ASA's (TRVX:...
Streetwise Reports | August 28, 2019 |

Will the 2020s Be Good or Bad for the Gold Market?

2010s have certainly been a roller coaster ride for gold. Will the 2020s then be better than the prior years for the yellow metal? Today’s article provides the macroeconomic outlook for the full decade – learn whether the fundamental factors will become in the ...
Arkadiusz Sieron | February 14, 2020 |

Novavax Shares Rise 9% Upon Initiating Phase 1/2 COVID-19 Vaccine Clinical Trial

Novavax shares traded higher after the company reported it enrolled the first participants in its Phase 1 clinical study of NVX CoV2373. Novavax Inc. (NVAX:NASDAQ) , which focuses its efforts on developing next-generation vaccines to address infectious diseases, ye...
Streetwise Reports | May 27, 2020 |
1 2 3 4 5 6 7 8 9 10 ...